Global Molecular Infectious Disease Testing Market Growth 2025-2031
Description
The global Molecular Infectious Disease Testing market size is predicted to grow from US$ 455 million in 2025 to US$ 624 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
Molecular Infectious Disease Testing refers to diagnostic tests that detect the genetic material (DNA or RNA) of infectious agents, such as bacteria, viruses, fungi, or parasites, to diagnose an infection. These tests are highly sensitive and can identify pathogens even when they are present in very low quantities, making them crucial for early detection and accurate diagnosis.
United States market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Molecular Infectious Disease Testing players cover Danaher, Roche, bioMérieux, Hologic, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Molecular Infectious Disease Testing Industry Forecast” looks at past sales and reviews total world Molecular Infectious Disease Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Infectious Disease Testing sales for 2025 through 2031. With Molecular Infectious Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Infectious Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global Molecular Infectious Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Infectious Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Infectious Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Infectious Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Infectious Disease Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Infectious Disease Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Multiplex Testing
Singleplex Testing
Segmentation by Application:
Diagnostic Laboratories
Hospitals and Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Danaher
Roche
bioMérieux
Hologic
Abbott
Thermo Fisher Scientific
QIAGEN
Revvity
Grifols
Seegene
DiaSorin
Siemens Healthineers
BD
QuidelOrtho
Bruker
Genetic Signatures
Co-Diagnostics
Vela Diagnostics
Molbio Diagnostics
Savyon Diagnostics
Uniogen Oy
geneOmbio Technologies
Advanced Molecular Diagnostics
altona Diagnostics
GeneFirst
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Infectious Disease Testing market?
What factors are driving Molecular Infectious Disease Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Infectious Disease Testing market opportunities vary by end market size?
How does Molecular Infectious Disease Testing break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Molecular Infectious Disease Testing refers to diagnostic tests that detect the genetic material (DNA or RNA) of infectious agents, such as bacteria, viruses, fungi, or parasites, to diagnose an infection. These tests are highly sensitive and can identify pathogens even when they are present in very low quantities, making them crucial for early detection and accurate diagnosis.
United States market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Molecular Infectious Disease Testing players cover Danaher, Roche, bioMérieux, Hologic, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Molecular Infectious Disease Testing Industry Forecast” looks at past sales and reviews total world Molecular Infectious Disease Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Infectious Disease Testing sales for 2025 through 2031. With Molecular Infectious Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Infectious Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global Molecular Infectious Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Infectious Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Infectious Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Infectious Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Infectious Disease Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Infectious Disease Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Multiplex Testing
Singleplex Testing
Segmentation by Application:
Diagnostic Laboratories
Hospitals and Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Danaher
Roche
bioMérieux
Hologic
Abbott
Thermo Fisher Scientific
QIAGEN
Revvity
Grifols
Seegene
DiaSorin
Siemens Healthineers
BD
QuidelOrtho
Bruker
Genetic Signatures
Co-Diagnostics
Vela Diagnostics
Molbio Diagnostics
Savyon Diagnostics
Uniogen Oy
geneOmbio Technologies
Advanced Molecular Diagnostics
altona Diagnostics
GeneFirst
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Infectious Disease Testing market?
What factors are driving Molecular Infectious Disease Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Infectious Disease Testing market opportunities vary by end market size?
How does Molecular Infectious Disease Testing break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
153 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Molecular Infectious Disease Testing by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Molecular Infectious Disease Testing by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
